Reducing spend is important, but shouldn't be your only priority when selecting a PBM. Chief Growth Officer Byron Mickle explains why strong...

Nearly 150 million people in the U.S. have at least one chronic illness, and as many as half fail to take their prescriptions appropriately.^1,2

In the second part of this two-part blog series, we’ll discuss a few tools that plan sponsors can use to effectively combat opioid abuse and...

During this two-part blog series, we'll discuss the opioid epidemic in its current state, the impact that coronavirus (COVID-19) is having on the...

Let’s compare two types of PBM contracts. A complex contract that may be filled with legalese or a simple contract with fewer pages. The PBM...

Formularies can often include drugs that have little to no clinical value and drive up costs. These are often referred to as wasteful or low-value...

It’s no secret that growing prescription drug costs are causing concern for plan sponsors and their members. Formularies can often include drugs...

Didn’t catch our webinar last week? Read on to see what you missed!

More than 75% of pharmaceutical manufacturers are choosing to limit the number of pharmacies that can dispense certain specialty medications.¹...

Is your PBM 100% transparent? If its not, it's time to take a closer look to see why.